Accelerate Timeline to Start PhI: Phase Appropriate Development and Integrated Drug Product Supply
Day 3 Manufacturing 5.0 Stage
08/10/2026 12:00 - 12:25pm
Contributors
Mimoun Ayoub : SVP, Commercial Head Peptides - CordenPharma
In the early phase of drug development for peptide APIs, speed to start Phase I is absolutely key. With our early phase development concept, including process and analytical development, we can strongly reduce the time to manufacturing Tox and first GMP material. Synchronised timelines and parallel workflows between drug substance and drug product within our PepCellerate™ platform allows to save time while reducing risks. A case study will be presented.